The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Combined Homologous Recombination Deficiency (HRD) scores and response to neoadjuvant platinum-based chemotherapy in triple-negative and/or BRCA1/2 mutation-associated breast cancer.
 
Melinda L. Telli
Consulting or Advisory Role - OncoPlex Diagnostics; Vertex
Research Funding - Abbvie; Biomarin; Calithera Biosciences; Novartis; PharmaMar; Sanofi
 
Kirsten Timms
Employment - Myriad Genetics
Stock and Other Ownership Interests - Myriad Genetics
 
Julia E. Reid
Employment - Myriad Genetics
Stock and Other Ownership Interests - Myriad Genetics
 
Christopher Neff
Employment - Myriad Genetics
Stock and Other Ownership Interests - Myriad Genetics
 
Victor Abkevich
Employment - Myriad Genetics
Stock and Other Ownership Interests - Myriad Genetics
 
Alexander Gutin
Employment - Myriad Genetics
Stock and Other Ownership Interests - Myriad Genetics
 
Zaina Sangale
Employment - Myriad Genetics
Stock and Other Ownership Interests - Myriad Genetics
 
Diana Illiev
Employment - Myriad Genetics
Stock and Other Ownership Interests - Myriad Genetics
 
Joshua Timothy Jones
Employment - Myriad Genetics
Stock and Other Ownership Interests - Myriad Genetics
 
Bryan Hennessy
No Relationships to Disclose
 
Jerry S. Lanchbury
Employment - Myriad Genetics
Leadership - Myriad Genetics
Stock and Other Ownership Interests - Myriad Genetics
 
Gordon B. Mills
Stock and Other Ownership Interests - Catena; PTV Sciences; Spindletop Ventures
Consulting or Advisory Role - AstraZeneca; Blend Therapeutics; Critical outcome technologies; HanAl Bio Korea; Illumina; Nuevolution; Pfizer; Provista Diagnostics; Roche Pharma AG; SignalChem; Symphony Evolution; Tau Therapeutics
Research Funding - adelson medical research foundation; AstraZeneca; Critical Outcome Technologies; GlaxoSmithKline; Illumina
 
Anne-Renee Hartman
Employment - Myriad Genetics
Stock and Other Ownership Interests - Myriad Genetics
 
James M. Ford
Consulting or Advisory Role - Natera
Research Funding - InVitae; Myriad Genetics; Varian Medical Systems